VivoSeq
Other

Spine Surgery

0

Pipeline Programs

9

Active Trials

0

Companies Involved

Spine Surgery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

40

clinical trials

Completed21 · 53%
Recruiting8 · 20%
Unknown status7 · 18%
Withdrawn3 · 8%
Not yet recruiting1 · 3%

Trial Activity

40 trials

Perioperative Rectal Methadone in Spine Surgery
Recruiting·UUnity Health Toronto·Phase 4·NCT06843174·40 enrolled
Preoperative Block for Anterior Cervical Spine Surgery
Not yet recruiting·TTanta University·Phase 3·NCT06867510·90 enrolled
Trial of Alvimopan in Major Spine Surgery
Completed·UUniversity of Virginia·Phase 4·NCT02789111·49 enrolled
GRASSP: Gralise® for Spine Surgery Pain
Completed·UUniversity of Rochester·Phase 4·NCT01764464·53 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)